Thyroid hormones and mitochondria: With a brief look at derivatives and analogues

Molecular and Cellular Endocrinology

Volumn 379, Issue 1-2, 2013, Pages 51-61

  Cioffi, Federica ^a   Senese, Rosalba ^b   Lanni, Antonia ^b   Goglia, Fernando ^a  

^a UNIVERSITY OF SANNIO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Iodothyronine; Mitochondrion; Thyroid hormone; Thyroid hormone analogue

Indexed keywords

3 IODOTHYRONAMINE; CELL PROTEIN; DIIODOTHYRONINE; EPROTIROME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR 1; LIOTHYRONINE; LIVER PROTECTIVE AGENT; MITOFUSIN 1; MITOFUSIN 2; MONOCARBOXYLATE TRANSPORTER 8; ORGANIC ANION TRANSPORTER 1C1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C ERBA K1; PROTEIN DRP1; PROTEIN P28; PROTEIN P43; RETINOIC ACID RECEPTOR; SOBETIROME; THYROID HORMONE; THYROID HORMONE DERIVATIVE; THYROID HORMONE RECEPTOR; THYROID HORMONE RECEPTOR BETA AGONIST; THYROXINE; THYROXINE DEIODINASE; TRIIODOTHYRONINE DERIVATIVE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 3; UNINDEXED DRUG;

BINDING AFFINITY; BINDING SITE; BIOGENESIS; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL RESPIRATION; CELLULAR DISTRIBUTION; DEIODINATION; DRUG ACTIVITY; DRUG POTENTIATION; DRUG STRUCTURE; EMBRYO DEVELOPMENT; FATTY LIVER; GENE; GENETIC TRANSCRIPTION; HEART DISEASE; HORMONAL REGULATION; HORMONE BINDING; HORMONE METABOLISM; HORMONE RELEASE; HORMONE RESPONSIVE ELEMENT; HORMONE STRUCTURE; HORMONE TRANSPORT; HUMAN; INSULIN SENSITIVITY; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL PLASTICITY; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE DISEASE; NONHUMAN; OLIGOMERIZATION; OSTEOLYSIS; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PLASTICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TACHYCARDIA; THYROID GLAND; TRALPHA GENE; TRBETA GENE; UNSPECIFIED SIDE EFFECT;

IODOTHYRONINE; MITOCHONDRION; THYROID HORMONE; THYROID HORMONE ANALOGUE;

CELL RESPIRATION; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 84884534711     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.06.006     Document Type: Review

References (125)

1. Aguer C., Harper M.E. Skeletal muscle mitochondrial energetics in obesity and type 2 diabetes mellitus: endocrine aspects. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26(6):805-819.
2. Antonelli A., Fallahi P., Ferrari S.M., Di Domenicantonio A., Moreno M., Lanni A., Goglia F. 3,5-Diiodo-l-thyronine increases resting metabolic rate and reduces body weight without undesirable side effects. J. Biol. Regul. Homeost. Agents 2011, 25(4):655-660.
3. Aquilano K., Vigilanza P., Baldelli S., Pagliei B., Rotilio G., Ciriolo M.R. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. B 2010, 285(28):21590-21599.
4. Arnold S., Goglia F., Kadenbach B. 3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. Eur. J. Biochem. 1998, 252(2):325-330.
5. Attia R.R., Connnaughton S., Boone L.R., Wang F., Elam M.B., Ness G.C., Cook G.A., Park E.A. Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). J. Biol. Chem. 2010, 285:2375-2385.
6. Axelband F., Dias J., Ferrão F.M., Einicker-Lamas M.J. Nongenomic signaling pathways triggered by thyroid hormones and their metabolite 3-iodothyronamine on the cardiovascular system. J. Cell. Physiol. 2011, 226(1):21-28.
7. Azzu V., Jastroch M., Divakaruni A.S., Brand M.D. The regulation and turnover of mitochondrial uncoupling proteins. Biochim. Biophys. Acta 2010, 1797(6-7):785-791.
8. Bassett J.H., Harvey C.B., Williams G.R. Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol. Cell. Endocrinol. 2003, 213(1):1-11.
9. Baxter J.D., Webb P. Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat. Rev. Drug Discov. 2009, 8:308-320.
10. Bergh J.J., Lin H.Y., Lansing L., Mohamed S.N., Davis F.B., Mousa S., Davis P.J. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005, 146(7):2864-2871.
11. Berkenstam A., Kristensen J., Mellstro M.K., Carlsson B., Malm J., Rehnmark S., Garg N., Andersson C.M., Rudling M., Sjo berg F., Angelin B., Baxter J.D. The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans. Proc. Natl. Acad. Sci. USA 2008, 105:663-667.
12. Bianco A.C. Minireview: cracking the metabolic code for thyroid hormone signaling. Endocrinology 2011, 152(9):3306-3311.
13. Bigler J., Hokanson W., Eisenman R.N. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor. Mol. Cell. Biol. 1992, 12(5):2406-2417.
14. Brent G.A. Mechanisms of thyroid hormone action. J. Clin. Invest. 2012, 122(9):3035-3043.
15. Carazo A., Levin J., Casas F., Seyer P., Grandemange S., Busson M., Pessemesse L., Wrutniak-Cabello C., Cabello G. Protein sequences involved in the mitochondrial import of the 3,5,3'-l-triiodothyronine receptor p43. J. Cell. Physiol. 2012, 227(12):3768-3777.
16. Chan I.H., Privalsky M.L. A conserved lysine in the thyroid hormone receptor-alpha1 DNA-binding domain, mutated in hepatocellular carcinoma, serves as a sensor for transcriptional regulation. Mol. Cancer Res. 2010, 8(1):15-23.
17. Chang C.R., Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N. Y. Acad. Sci. 2010, 1201:34-39.
18. Chen H., Chomyn A., Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 2005, 280(28):26185-26192.
19. Cheng S.Y., Leonard J.L., Davis P.J. Molecular aspects of thyroid hormone actions. Endocr. Rev. 2010, 31(2):139-170.
20. Cioffi F., Senese R., de Lange P., Goglia F., Lanni A., Lombardi A. Uncoupling proteins: a complex journey to functions discovery. BioFactors 2009, 35:417-428.
21. Cioffi F., Lanni A., Goglia F. Thyroid hormones, mitochondrial bioenergetics and lipid handling. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17(5):402-407.
22. Cipolat S., de Brito O.M., Dal Zilio B., Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA 2004, 101(45):15927-15932.
23. Cody V., Davis P.J., Davis F.B. Molecular modeling of the thyroid hormone interactions with alpha v beta 3 integrin. Steroids 2007, 72(2):165-170.
24. Davis P.J., Davis F.B., Lin H.Y., Mousa S.A., Zhou M., Luidens M.K. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am. J. Physiol. Endocrinol. Metab. 2009, 297(6):E1238-E1246.
25. de Brito O.M., Scorrano L. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. Mitochondrion 2009, 9(3):222-226.
26. de Lange P., Lanni A., Beneduce L., Moreno M., Lombardi A., Silvestri E., Goglia F. Uncoupling protein-3 is a molecular determinant for the regulation of resting metabolic rate by thyroid hormone. Endocrinology 2001, 142:3414-3420.
27. de Lange P., Senese R., Cioffi F., Moreno M., Lombardi A., Silvestri E., Goglia F., Lanni A. Rapid activation by 3,5,3'-l-triiodothyronine of adenosine 5'-monophosphate-activated protein kinase/acetyl-coenzyme a carboxylase and akt/protein kinase B signaling pathways: relation to changes in fuel metabolism and myosin heavy-chain protein content in rat gastrocnemius muscle in vivo. Endocrinology 2008, 149(12):6462-6470.
28. de Lange P., Cioffi F., Senese R., Moreno M., Lombardi A., Silvestri E., De Matteis R., Lionetti L., Mollica M.P., Goglia F., Lanni A. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-l-thyronine in rats. Diabetes 2011, 60(11):2730-2739.
29. De Stefani D., Raffaello A., Teardo E., Szabo I., Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 2011, 476:336-340.
30. 2+]i elevations induced by iodothyronines (T3 and T2) in pituitary GH3 cells. Am. J. Physiol. Endocrinol. Metab. 2012, 302(11):E1419-E1430.
31. Dentice M., Salvatore D. Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J. Endocrinol. 2011, 209(3):273-282.
32. Desouza L.A., Ladiwala U., Daniel S.M., Agashe S., Vaidya R.A., Vaidya V.A. Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Mol. Cell. Neurosci. 2005, 29(3):414-426.
33. Detmer S.A., Chan D.C. Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. J. Cell Biol. 2007, 176(4):405-414.
34. Enríquez J.A., Fernández-Silva P., Garrido-Pérez N., López-Pérez M.J., Pérez-Martos A., Montoya J. Direct regulation of mitochondrial RNA synthesis by thyroid hormone. Mol. Cell. Biol. 1999, 19(1):657-670.
35. Farach-Carson M.C., Davis P.J. Steroid hormone interactions with target cells: cross talk between membrane and nuclear pathways. J. Pharmacol. Exp. Ther. 2003, 307(3):839-845.
36. Farwell A.P., Dubord-Tomasetti S.A., Pietrzykowski A.Z., Leonard J.L. Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology 2006, 147:2567-2574.
37. Flamant F., Gauthier K. Thyroid hormone receptors: the challenge of elucidating isotype-specific functions and cell-specific response. Biochim. Biophys. Acta 2012, June 13.
38. Flandin P., Lehr L., Asensio C., Giacobino J.P., Rohner-Jeanrenaud F., Muzzin P., Jimenez M. Uncoupling protein-3 as a molecular determinant of the action of 3,5,3'-triiodothyronine on energy metabolism. Endocrine 2009, 36(2):246-254.
39. Frascarelli S., Ghelardoni S., Chiellini G., Galli E., Ronca F., Scanlan T.S., Zucchi R. Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. Cardiovasc. Drugs Ther. 2011, 25(4):307-313.
40. Friesema E.C., Ganguly S., Abdalla A., Manning Fox J.E., Halestrap A.P., Visser T.J. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J. Biol. Chem. 2003, 278(41):40128-40135.
41. Gadaleta M.N., Barletta A., Caldarazzo M., De Leo T., Saccone C. Triiodothyronine action on RNA synthesis in rat-liver mitochondria. Eur. J. Biochem. 1972, 30(2):376-381.
42. Goglia F. Biological effects of 3,5-diiodothyronine (T2). Biochemistry (Mosc.) 2005, 70(2):164-172.
43. Goglia F., Skulachev V.P. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J. 2003, 17(12):1585-1591.
44. Goglia F., Torresani J., Bugli P., Barletta A., Liverini G. In vitro binding of triiodothyronine to rat liver mitochondria. Pflug. Arch. 1981, 390(2):120-124.
45. Goglia F., Liverini G., De Leo T., Barletta A. Thyroid state and mitochondrial population during cold exposure. Pflug. Arch. 1983, 396(1):49-53.
46. Goglia F., Lanni A., Barth J., Kadenbach B. Interaction of diiodothyronines with isolated cytochrome c oxidase. FEBS Lett. 1994, 346(2-3):295-298.
47. Goglia F., Lanni A., Horst C., Moreno M., Thoma R. In vitro binding of 3,5-di-iodo-l-thyronine to rat liver mitochondria. J. Mol. Endocrinol. 1994, 13(3):275-282.
48. Hailey D.W., Rambold A.S., Satpute-Krishnan P., Mitra K., Sougrat R., Kim P.K., Lippincott-Schwartz J. Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010, 141(4):656-667.
49. Hess B., Martius C. The mode of action of thyroxin. Arch. Biochem. Biophys. 1951, 33(3):486-487.
50. Hock M.B., Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu. Rev. Physiol. 2009, 71:177-203.
51. Huang C.J., Geller H.M., Green W.L., Craelius W. Acute effects of thyroid hormone analogs on sodium currents in neonatal rat myocytes. J. Mol. Cell. Cardiol. 1999, 31(4):881-893.
52. Incerpi S., De Vito P., Luly P., Spagnuolo S., Leoni S. Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 2002, 143(5):1660-1668.
53. Irrcher I., Adhihetty P.J., Sheehan T., Joseph A.M., Hood D.A. PPARgamma coactivator-1alpha expression during thyroid hormone- and contractile activity-induced mitochondrial adaptations. Am. J. Physiol. Cell Physiol. 2003, 284(6):C1669-C1677.
54. Irrcher I., Walkinshaw D.R., Sheehan T.E., Hood D.A. Thyroid hormone (T3)rapidly activates p38 and AMPK in skeletal muscle in vivo. J. Appl. Physiol. 2008, 104:178-185.
55. Kapoor R., van Hogerlinden M., Wallis K., Ghosh H., Nordstrom K., Vennstrom B., Vaidya V.A. Unliganded thyroid hormone receptor alpha1 impairs adult hippocampal neurogenesis. FASEB J. 2010, 24(12):4793-4805.
56. Kinne A., Schülein R., Krause G. Primary and secondary thyroid hormone transporters Thyroid Research 2011, 4(Suppl. 1):S7.
57. Koshiba T., Detmer S.A., Kaiser J.T., Chen H., McCaffery J.M., Chan D.C. Structural basis of mitochondrial tethering by mitofusin complexes. Science 2004, 305(5685):858-862.
58. Kuznetsov A.V., Hermann M., Saks V., Hengster P., Margreiter R. The cell-type specificity of mitochondrial dynamics. Int. J. Biochem. Cell Biol. 2009, 41(10):1928-1939.
59. Ladenson P.W., Kristensen J.D., Ridgway E.C., Olsson A.G., Carlsson B., Klein I., Baxter J.D., Angelin B. Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia. N. Engl. J. Med. 2010, 362(10):906-916.
60. Lanni A., Moreno M., Cioffi M., Goglia F. Effect of 3,3'-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity. Mol. Cell. Endocrinol. 1992, 86:143-148.
61. Lanni A., Moreno M., Cioffi M., Goglia F. Effect of 3,3'-di-iodothyronine and 3,5-di-iodothyronine on rat liver mitochondria. J. Endocrinol. 1993, 136:59-64.
62. Lanni A., Moreno M., Lombardi A., Goglia F. Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-l-thyronine and by 3,3'-diiodo-l-thyronine. Mol. Cell. Endocrinol. 1994, 99(1):89-94.
63. Lanni A., De Felice M., Lombardi A., Moreno M., Fleury C., Ricquier D., Goglia F. Induction of UCP2 mRNA by thyroid hormones in rat heart. FEBS Lett. 1997, 418:171-174.
64. Lanni A., Beneduce L., Lombardi A., Moreno M., Boss O., Muzzin P., Giacobino J.P., Goglia F. Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle. FEBS Lett. 1999, 444:250-254.
65. Lanni A., Moreno M., Lombardi A., de Lange P., Goglia F. Control of energy metabolism by iodothyronines. J. Endocrinol. Invest. 2001, 24(11):897-913.
66. Lanni A., Moreno M., Lombardi A., Goglia F. Thyroid hormone and uncoupling proteins. FEBS Lett. 2003, 543:5-10.
67. Lanni A., Moreno M., Lombardi A., de Lange P., Silvestri E., Ragni M., Farina P., Baccari G.C., Fallahi P., Antonelli A., Goglia F. 3,5-Diiodo-l-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J. 2005, 19(11):1552-1554.
68. Lardy H.A., Feldott G. Metabolic effects of thyroxine in vitro. Ann. N. Y. Acad. Sci. 1951, 54(4):636-648.
69. Leo T., Meo S., Barletta A., Martino G., Goglia F. Modification of nucleic acid levels per mitochondrion induced by thyroidectomy or triiodothyronine administration. Pflug. Arch. 1976, 366(1):73-77.
70. Liesa M., Palacín M., Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol. Rev. 2009, 89(3):799-845.
71. Lin H.Y., Tang H.Y., Shih A., Keating T., Cao G., Davis P.J., Davis F.B. Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 2007, 72(2):180-187.
72. Lin H.Y., Tang H.Y., Keating T., Wu Y.H., Shih A., Hammond D., Sun M., Hercbergs A., Davis F.B., Davis P.J. Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated. Carcinogenesis 2008, 29:62-69.
73. Lin H.Y., Sun M., Lin C., Tang H.Y., London D., Shih A., Davis F.B., Davis P.J. Androgen induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells. J. Steroid Biochem. Mol. Biol. 2009, 113:182-188.
74. Lin H.Y., Sun M., Tang H.Y., Lin C., Luidens M.K., Mousa S.A., Incerpi S., DrusanoG L., Davis F.B., Davis P.J. l-Thyroxine vs. 3,5,3-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Am. J. Physiol. Cell Physiol. 2009, 296:C980-C991.
75. Magnus-Levy A. Ueber den respiratorishen Gaswechsel unter Einfluss der Thyroidea sowie unter verschieden pathologische Zustand. Berliner Klinische Wochenshrift 1895, 32:650-652.
76. Martino G., Covello C., De Giovanni R., Filippelli R., Pitrelli G. Direct in vitro action of thyroid hormones on mitochondrial RNA-polymerase. Mol. Biol. Rep. 1986, 11(4):205-211.
77. Mayerl S., Visser T.J., Darras V.M., Horn S., Heuer H. Endocrinology 2012, 153(3):1528-1537.
78. Meeusen S., McCaffery J.M., Nunnari J. Mitochondrial fusion intermediates revealed in vitro. Science 2004, 305(5691):1747-1752.
79. Michel S., Wanet A., De Pauw A., Rommelaere G., Arnould T., Renard P. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J. Cell. Physiol. 2012, 227(6):2297-2310.
80. Moeller L.C., Dumitrescu A.M., Refetoff S. Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1_ and glycolytic genes. Mol. Endocrinol. 2005, 19:2955-2963.
81. Morel G., Ricard-Blum S., Ardail D. Kinetics of internalization and subcellular binding sites for T3 in mouse liver. Biol. Cell 1996, 86(2-3):167-174.
82. Moreno M., de Lange P., Lombardi A., Silvestri E., Lanni A., Goglia F. Metabolic effects of thyroid hormone derivatives. Thyroid 2008, 18(2):239-253.
83. Moreno M., Silvestri E., De Matteis R., de Lange P., Lombardi A., Glinni D., Senese R., Cioffi F., Salzano A.M., Scaloni A., Lanni A., Goglia F. 3,5-Diiodo-l-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J. 2011, 25(10):3312-3324.
84. Mutvei A., Kuzela S., Nelson B.D. Control of mitochondrial transcription by thyroid hormone. Eur. J. Biochem. 1989, 180(1):235-240.
85. Nelson B.D., Luciakova K., Li R., Betina S. The role of thyroid hormone and promoter diversity in the regulation of nuclear encoded mitochondrial proteins. Biochim. Biophys. Acta 1995, 271(1):85-91.
86. Oetting A., Yen P.M. New insights into thyroid hormone action. Best Pract. Res. Clin. Endocrinol. Metab. 2007, 21(2):193-208.
87. Oppenheimer J.H., Schwartz H.L., Surks M.I. Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen and testis. Endocrinology 1974, 95:897-903.
88. O'Reilly I., Murphy M.P. Studies on the rapid stimulation of mitochondrial respiration by thyroid hormones. Acta Endocrinol. (Copenh.) 1992, 127(6):542-546.
89. Orozco A., Valverde R.C., Olvera A., García G.C. Iodothyronine deiodinases: a functional and evolutionary perspective. J. Endocrinol. 2012, 215(2):207-219.
90. Osellame L.D., Blacker T.S., Duchen M.R. Cellular and molecular mechanisms of mitochondrial function. Best Pract. Res. Clin. Endocrinol. Metab. 2012, 26(6):711-723.
91. Otera H., Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J. Biochem. 2011, 149(3):241-251.
92. Pessemesse L., Schlernitzauer A., Sar C., Levin J., Grandemange S., Seyer P., Favier F.B., Kaminski S., Cabello G., Wrutniak-Cabello C., Casas F. Depletion of the p43 mitochondrial T3 receptor in mice affects skeletal muscle development and activity. FASEB J. 2012, 26(2):748-756.
93. Picard F., Géhin M., Annicotte J., Rocchi S., Champy M.F., O'Malley B.W., Chambon P., Auwerx J. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 2002, 111(7):931-941.
94. Piehl S., Hoefig C.S., Scanlan T.S., Köhrle J. Thyronamines past, present, and future. Endocr. Rev. 2011, 32(1):64-80.
95. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998, 92:829-839.
96. Rosen M.D., Chan I.H., Privalsky M.L. Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas. Mol. Endocrinol. 2011, 25(8):1311-1325.
97. Sadana P., Zhang Y., Song S., Cook G.A., Elam M.B., Park E.A. Regulation of carnitine palmitoyltransferase I (CPT-I alpha) gene expression by the peroxisome proliferator activated receptor gamma coactivator (PGC-1) isoforms. Mol. Cell. Endocrinol. 2007, 267:6-16.
98. Saelim N., John L.M., Wu J., Park J.S., Bai Y., Camacho P., Lechleiter J.D. Nontranscriptional modulation of intracellular Ca2+ signaling by ligand stimulated thyroid hormone receptor. J. Cell Biol. 2004, 167(5):915-924.
99. Samuels H.H., Tsai J.S., Casanova J. Thyroid hormone action: in vitro demonstration of putative receptors in isolated nuclei and soluble nuclear extracts. Science 1974, 184(4142):1188-1191.
100. Sap J., Muñoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H., Vennström B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986, 324(6098):635-640.
101. Silva J.E. Thermogenic mechanisms and their hormonal regulation. Physiol. Rev. 2006, 86(2):435-464.
102. Silvestri E., Schiavo L., Lombardi A., Goglia F. Thyroid hormones as molecular determinants of thermogenesis. Acta Physiol. Scand. 2005, 184:265-283.
103. Silvestri E., Cioffi F., Glinni D., Ceccarelli M., Lombardi A., de Lange P., Chambery A., Severino V., Lanni A., Goglia F., Moreno M. Pathways affected by 3,5-diiodo-l-thyronine in liver of high fat-fed rats: evidence from two-dimensional electrophoresis, blue-native PAGE, and mass spectrometry. Mol. BioSyst. 2010, 6(11):2256-2271.
104. Sterling K., Milch P.O. Thyroid hormone binding by a component of mitochondrial membrane. Proc. Natl. Acad. Sci. USA 1975, 72(8):3225-3229.
105. Tata J.R. Inhibition of the biological action of thyroid hormones by actinomycin D and puromycin. Nature 1963, 197:1167-1168.
106. Tata J.R. The road to nuclear receptors of thyroid hormone. Biochim. Biophys. Acta 2012, March 17.
107. Tata J.R., Ernster L., Lindberg O. Control of basal metabolic rate by thyroid hormones and cellular function. Nature 1962, 193:1058-1060.
108. Tata J.R., Ernster L., Lindberg O., Arrhenius E., Pedersen S., Hedman R. The action of thyroid hormones at the cell level. Biochem. J. 1963, 86(3):408-428.
109. Thakran S., Sharma P., Attia R.R., Hori R.T., Deng X., Elam M.B., Park E.A. Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone. J. Biol. Chem. 2013, 288(2):807-818.
110. Vatner D.F., Weismann D., Beddow S.A., Kumashiro N., Erion D.M., Liao X-H., Grover G.J., Webb P., Phillips K.J., Weiss R.E., Bogan J.S., Baxter J., Shulman G.I., Varman T., Samuel V.T. Thyroid hormone receptor β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. Am. J. Physiol. Endocrinol. Metab. 2013, May 7. 10.1152/ajpendo.00573.20.
111. Venditti P., Bari A., Di Stefano L., Cardone A., Della Ragione.F., D'Esposito M., Di Meo S. Involvement of PGC-1, NRF-1, and NRF-2 in metabolic response by rat liver to hormonal and environmental signals. Mol. Cell. Endocrinol. 2009, 305(1-2):22-29.
112. Venditti P., Chiellini G., Di Stefano L., Napolitano G., Zucchi R., Columbano A., Scanlan T.S., Di Meo S. The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine. J. Endocrinol. 2010, 2010(205):279-289.
113. Ventura-Clapier R., Garnier A., Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc. Res. 2008, 79(2):208-217.
114. Visser W.E., Friesema E.C., Visser T.J. Minireview: thyroid hormone transporters: the knowns and the unknowns. Mol. Endocrinol. 2011, 25(1):1-14.
115. Weinberger C., Thompson C.C., Ong E.S., Lebo R., Gruol D.J., Evans R.M. The c-erb-A gene encodes a thyroid hormone receptor. Nature 1986, 324(6098):641-646.
116. Weiss R.E., Xu J., Ning G., Pohlenz J., O'Malley B.W., Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO J. 1999, 18(7):1900-1904.
117. Weitzel J.M., Iwen K.A. Coordination of mitochondrial biogenesis by thyroid hormone. Mol. Cell. Endocrinol. 2011, 342(1-2):1-7.
118. Weitzel J.M., Iwen K.A., Seitz H.J. Regulation of mitochondrial biogenesis by thyroid hormone. Exp. Physiol. 2003, 88(1):121-128.
119. West A.P., Shadel G.S., Ghosh S. Mitochondria in innate immune responses. Nat. Rev. Immunol. 2011, 11(6):389-402.
120. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 2010, 11(12):872-884.
121. Wrutniak C., Cassar-Malek I., Marchal S., Rascle A., Heusser S., Keller J.M., Fléchon J., Dauça M., Samarut J., Ghysdael J., Cabello G. A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. J. Biol. Chem. 1995, 270(27):16347-16354.
122. Wulf A., Harneit A., Weitzel J.M. T3-mediated gene expression is independent of PGC-1alpha. Mol. Cell. Endocrinol. 2007, 270(1-2):57-63.
123. Wulf A., Harneit A., Kröger M., Kebenko M., Wetzel M.G., Weitzel J.M. T3-mediated expression of PGC-1alpha via a far upstream located thyroid hormone response element. Mol. Cell. Endocrinol. 2008, 287(1-2):90-95.
124. Yehuda-Shnaidman E., Kalderon B., Azazmeh N., Bar-Tana J. Gating of the mitochondrial permeability transition pore by thyroid hormone. FASEB J. 2010, 24:93-104.
125. Yen P.M., Ando S., Feng X., Liu Y., Maruvada P., Xia X. Thyroid hormone action at the cellular, genomic and target gene levels. Mol. Cell. Endocrinol. 2006, 246(1-2):121-127.